PMA P150013S030

Device
PD-L1 IHC 22C3 PHARMDX
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S030
Product code
PLS
Decision date
2025-06-27
Classification
Pathology
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
approval for incorporating a fill-volume tolerance range and software into a vial-filling process

Current openFDA PMA Record#

Device
PD-L1 IHC 22C3 PHARMDX
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S030
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2025-06-27
Decision code
OK30
Date received
2025-04-16
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
approval for incorporating a fill-volume tolerance range and software into a vial-filling process